Epigral Limited (EPIGRAL) — Announcement

· NSE 🔴 High Importance Neutral
📢 Key Event
CRISIL reaffirms Epigral's credit ratings at AA/Stable and A1+
💡 Investor Takeaway
The reaffirmation confirms Epigral's unchanged credit quality and access to bank financing.

Epigral Limited received a reaffirmation of its CRISIL credit ratings on July 13, 2026, confirming a Long Term rating of CRISIL AA/Stable and a Short Term rating of CRISIL A1+ for its total bank loan facilities of Rs. 1050 crores. The revision reflects no change in rating status but underscores continued confidence in the company's financial obligations. This reaffirmation maintains existing investor expectations regarding creditworthiness without altering capital structure assumptions.

📄 View Original Announcement (PDF)

About Epigral Limited (EPIGRAL)

Chemicals · Chemicals & Petrochemicals · Listed on NSE

Market Cap: ₹5,247.71 Cr P/E: 14.6

View full EPIGRAL stock details →

📡 Get AI alerts when EPIGRAL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track EPIGRAL — Free

📊 More EPIGRAL filings

See all EPIGRAL filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when EPIGRAL files new disclosures

Track EPIGRAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track EPIGRAL — Free

Free account · 2 AI queries/day